Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- ZoAnn E Dreyer
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Harbor-University of California at Los Angeles Medical Center
Torrance, California, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Advocate Children'S Hospital-Oak Lawn
Oak Lawn, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Norton Children'S Hospital
Louisville, Kentucky, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- the Steven and Alexandra Cohen Children'S Medical Center of New York
New Hyde Park, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Dayton Children'S Hospital
Dayton, Ohio, United States
- Legacy Emanuel Children'S Hospital
Portland, Oregon, United States
- Legacy Emanuel Hospital and Health Center
Portland, Oregon, United States
- Children'S Oncology Group
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Methodist Children'S Hospital of South Texas
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2009
- Primary completion
- 30 Jun 2014
- Completion
- 31 Mar 2021
- Last update posted
- 27 Apr 2021
- Registered enrollment
- 104
- Registry id
- NCT00866307
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.